Increased use of ophthalmic tests results in increased scrutiny

WAILEA, Hawaii — Among ophthalmic tests, use of immunoassays more than doubled in the past year.
Use of these tests, such as Quidel’s InflammaDry MMP-9, increased 118%, from approximately 36,000 procedures to 79,000 procedures and resulted in increased audits and decreased reimbursement, according to Kevin J. Corcoran, COE, CPC, CPMA, FNAO.
“So, if you are doing a ton of this testing, be aware,” Corcoran said at Hawaiian Eye 2018.
In ophthalmic imaging, even though the increase in percentage of OCT scans done in association with retinal injections is relatively low, only

Full Story →